2018 9月 14
BDA advises Zoetis on the sale of its plant health business in Japan to Nippon Soda
Divested plant health business in Japan to Nisso
2018
BDA Partners acted as exclusive financial advisor to Zoetis Inc. (www.zoetis.com) on the divestment of its Plant Health business in Japan to Nippon Soda Co., Ltd. The transaction closed on September 14th.
About Nippon Soda
Nippon Soda Co., Ltd. develops, produces, and commercializes chemicals, agrochemicals, and other products in Japan and internationally. Nippon Soda Co., Ltd. was founded in 1920 and is headquartered in Tokyo, Japan. www.nippon-soda.co.jp
About BDA
BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 20 years’ experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Tokyo, Seoul, Shanghai, Hong Kong, Ho Chi Minh City, Singapore and Mumbai. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services and Technology sectors. We work relentlessly to earn our clients’ trust by delivering insightful advice and outstanding outcomes. www.bdapartners.com
BDA formed partnerships with William Blair & Company in 2011 and Development Bank of Japan in 2017.
US securities transactions are performed by BDA Partners’ affiliate, BDA Advisors Inc, a broker-dealer registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc. is a member of the Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorised and regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.
Recent transactions
Agreed to divest East Syracuse, New York facility to LOTTE Corporation
2022
Sold minority stake to Quadria Capital
2022
Debt and equity restructuring
2022
Acquired by Novo Holdings
2022
Investment from The Riverside Company
2021
Acquired by Koura
2021
Acquired by MicroPort
2021
Divested majority stake in OPV Pharmaceuticals to RV Healthcare
2021
Divested Amazon Papyrus Chemicals Group to The Longreach Group
2021
Acquired by Mindray
2021
Divested majority stake to DCP Capital
2021
Divested China phenolic resins plant to Red Avenue
2021
Agreed to divest Couvet, Switzerland facility to WuXi AppTec
2021
Raised Series B round from ABC World Asia
2021
Divested Neoss to CareCapital
2020
Divested Escientia Life Sciences to Deccan Fine Chemicals
2020
Divested Epolin Chemicals to Chroma Color
2020
Divested significant stake in Kehua Bio-Engineering to Gree Real Estate
2020
Divested Asian electronic cleaning chemicals business to Nippon Kayaku
2020
Divested LAP Laser to IK Investment Partners
2019